Showing results 1 to 20 of 26
next >
Issue Date | Title | Author(s) |
1-May-2021 | A meta-analysis of medications directed against PCSK9 in familial hypercholesterolemia | Brandts, J; Dharmayat, KI; Vallejo-Vaz, AJ; Azar Sharabiani, MT; Jones, R, et al |
14-Jul-2018 | Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract | Mach, F; Ray, KK; Wiklund, O; Corsini, A; Catapano, AL, et al |
1-Dec-2020 | Characteristics of adults with heterozygous familial hypercholesterolaemia stratified by gender: preliminary analysis from the eas fhsc global registry on over 36,000 cases of familial hypercholesterolaemia | Vallejo-Vaz, AJ; Dharmayat, K; Stevens, C; Lyons, A; Brandts, J, et al |
27-May-2016 | Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel | Santos, RD; Gidding, SS; Hegele, RA; Cuchel, MA; Barter, PJ, et al |
Jun-2023 | Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11 | Koenig, W; Ray, KK; Landmesser, U; Leiter, LA; Schwartz, GG, et al |
25-May-2015 | Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment | Wiegman, A; Gidding, SS; Watts, GF; Chapman, MJ; Ginsberg, HN, et al |
15-Aug-2013 | Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease | Nordestgaard, BG; Chapman, MJ; Humphries, SE; Ginsberg, HN; Masana, L, et al |
18-Sep-2015 | Familial hypercholesterolaemia: a global call to arms | Vallejo-Vaz, AJ; Seshasai, SRK; Della, C; Hovingh, GK; Kastelein, JJP, et al |
1-Jun-2020 | Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care | Watts, GF; Gidding, SS; Mata, P; Pang, J; Sullivan, DR, et al |
6-Nov-2021 | Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) | Vallejo-Vaz, AJ; Stevens, CAT; Lyons, ARM; Dharmayat, KI; Freiberger, T, et al |
Aug-2022 | Global perspective of paediatric Familial Hypercholesterolaemia: Analysis from the EAS FHSC registry on over 11,200 children and adolescents with heterozygous Familial Hypercholesterolaemia from 44 countries | Dharmayat, KI; Vallejo-Vaz, AJ; Stevens, CA; Lyons, AR; Catapano, AL, et al |
1-Dec-2020 | Heterozygous familial hypercholesterolaemia in children: preliminary analysis from the eas fhsc global registry on over 7,900 children with familial hypercholesterolaemia | Dharmayat, K; Stevens, C; Lyons, A; Catapano, AL; Freiberger, T, et al |
22-Jul-2014 | Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society | Cuchel, M; Bruckert, E; Ginsberg, HN; Raal, FJ; Santos, RD, et al |
1-Aug-2022 | Identification, characteristics and management of adults with heterozygous Familial Hypercholesterolaemia in high and non-high income countries participating in the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) | Vallejo-Vaz, A; Stevens, C; Dharmayat, K; Lyons, A; Brandts, J, et al |
16-Apr-2020 | Inclisiran for the treatment of heterozygous familial hypercholesterolemia | Raal, FJ; Kallend, D; Ray, KK; Turner, T; Koenig, W, et al |
1-Dec-2023 | International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia | Watts, GF; Gidding, SS; Hegele, RA; Raal, FJ; Sturm, AC, et al |
24-Apr-2017 | Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic and clinical studies A Consensus Statement from the European Atherosclerosis Society Consensus Panel | Ference, BA; Ginsberg, HN; Graham, I; Ray, KK; Packard, CJ, et al |
Jun-2020 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel | Borén, J; Chapman, MJ; Krauss, RM; Packard, CJ; Bentzon, JF, et al |
1-Oct-2018 | Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) | Vallejo-Vaz, AJ; De Marco, M; Stevens, CAT; Akram, A; Freiberger, T, et al |
7-Dec-2016 | Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration | Vallejo-Vaz, A; Akram,, A; Seshasai,, R; Cole,, D; Watts, GF, et al |